Actively Recruiting
Diagnosis and Management of Inflammatory and Infectious Diseases
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-05-22
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating patients with diagnosed or undiagnosed inflammatory and infectious diseases that are not covered by previous studies. The goal is to collect important clinical, immunologic, and metabolic data to better understand these illnesses and provide a resource for future research. This observational study has been ongoing since 1978 and is considered minimal risk. Participants with a variety of infections and inflammatory diseases are enrolled and managed according to accepted medical practice. Once diagnosed, patients may be referred to other NIH protocols for follow-up or receive standard clinical care through outside providers or this protocol if specialized care is unavailable. The study does not involve experimental treatments but focuses on evaluation and data collection. During the study, participants undergo medical history and physical exams, laboratory tests, and other clinical assessments during initial and follow-up clinic visits. Researchers collect clinical specimens, medical records, and in-person evaluations to monitor disease features and treatment outcomes. The study provides ongoing observation and care supervision, with participation open to individuals aged 3 to 100 years.
CONDITIONS
Brief Title
Diagnosis and Management of Inflammatory and Infectious Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Known or suspected exposure to infection or presence of infectious or inflammatory disease symptoms
- Age 3 years and older
- NIH investigator willing to supervise participant's medical care at NIH
- Having a primary physician outside NIH
- Ability to provide informed consent or have a legally authorized representative provide consent
You will not qualify if you...
- Pregnant individuals
- Conditions that may pose undue risk or make participation unsuitable as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies based on individual diagnostic needs
Participants undergo evaluations to diagnose infectious and inflammatory diseases through clinical assessments, labs, and specimen collection.
Initial and follow-up clinic visits as needed
Duration - Ongoing throughout participation
Participants are observed over time to collect data and monitor their infectious or inflammatory conditions, contributing to a repository for future research.
Follow-up visits according to clinical care and research needs
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
R
Rosemary McConnell, R.N.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here